Efficacy of LOw-dose DObutamine Stress-Echocardiography to predict Cardiac Resynchronization Therapy Response (LODO-CRT) multicenter prospective study-Design and rationale

American Heart Journal

Volumn 156, Issue 4, 2008, Pages 656-661

  Muto, Carmine ^a   Gasparini, Maurizio ^b   Iacopino, Saverio ^c   Peraldo, Carlo ^d   Curnis, Antonio ^e   Sassone, Biagio ^f   Diotallevi, Paolo ^g   Davinelli, Mario ^h   Valsecchi, Sergio ^h   Tuccillo, Bernardino ^a  

^a Ospedale Loreto Mare   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Sant'Anna Hospital   (Italy)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

^e SPEDALI CIVILI   (Italy)

^f Ospedale Consorziale   (Italy)

^g C Arrigo Children's Hospital   (Italy)

^h Clinical Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; LOW DRUG DOSE; METHODOLOGY; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRESS ECHOCARDIOGRAPHY; TREATMENT RESPONSE;

CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY, STRESS; HUMANS; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RESEARCH DESIGN; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 52949086756     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.06.011     Document Type: Article

References (36)

1. Auricchio A., Stellbrink C., Sack S., et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39 (2002) 2026-2033
2. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intra-ventricular conduction delay. N Engl J Med 344 (2001) 873-880
3. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
4. Young J.B., Abraham W.T., Smith A.L., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 289 (2003) 2685-2694
5. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
6. Auricchio A., Stellbrink C., Butter C., et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 42 (2003) 2109-2116
7. Bax J.J., Van der Wall E.E., and Schalij M.J. Cardiac resynchronization therapy for heart failure. N Engl J Med 347 (2002) 1803-1804
8. Cleland J., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
9. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 112 (2005) 1116-1143
10. Vardas P.E., Auricchio A., Blanc J.J., et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28 (2007) 2256-2295
11. Yu C.M., Fung J.W., Chan C.K., et al. Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure. J Cardiovasc Electrophysiol 15 (2004) 1058-1065
12. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 734-743
13. Birnie D.H., and Tang A.S.L. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 21 (2006) 20-26
14. Gasparini M., Mantica M., Galimberti P., et al. Is the outcome of cardiac resynchronization therapy related to the underlying etiology?. Pacing Clin Electrophysiol 26 (2003) 175-180
15. Gasparini M., Mantica M., Galimberti P., et al. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy?. Pacing Clin Electrophysiol 26 (2003) 162-168
16. Pitzalis M.V., Iacoviello M., Romito R., et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 40 (2002) 1615-1622
17. Yu C.M., Zhang O., Fung J.W., et al. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J Am Coll Cardiol 45 (2005) 677-684
18. Bax J.J., Bleeker G.B., Marwick T.H., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
19. Marcus G.M., Rose E., Viloria E.M., et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 46 (2005) 2208-2214
20. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117 (2008) 2608-2616
21. Cigarroa C.G., De Filippi C.R., Brickner M.E., et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 88 (1993) 430-436
22. La Canna G., Alfieri O., Giubbibi R., et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 23 (1994) 617-626
23. Marmor A., and Scneeweiss A. Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 29 (1997) 422-428
24. Pinamonti B., Perkan A., Di Lenarda A., et al. Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur J Heart Fail 4 (2002) 49-61
25. Seghatol F.F., Shah D.J., Diluzio S., et al. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 93 (2004) 854-859
26. Da Costa A., Thevenin J., Roche F., et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm 3 (2006) 406-413
27. Cleland J.G., Daubert J.C., Erdmann E., et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 3 (2001) 481-489
28. Penicka M., Bartunek J., De Bruyne B., et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 109 (2004) 978-983
29. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 7 (2001) 176-182
30. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantization of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantization of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
31. Agricola E., Oppizzi M., Pisani M., and Margonato A. Stress echocardiography in heart failure. Cardiovasc Ultrasound 2 (2004) 11
32. Yu C.M., Bleeker G.B., Fung J.W.H., et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112 (2005) 1580-1586
33. Tuccillo B., Muto C., Ascione L., et al. Usefulness of left ventricular contractile reserve by dobutamine stress echocardiography as an effective tool to predict response to cardiac resynchronization therapy. Heart Rhythm 3 1S (2006) S25
34. Hawkins N.M., Petrie M.C., MacDonald M.R., et al. Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony?. Eur Heart J 27 (2006) 1270-1281
35. White J.A., Yee R., Yuan X., et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intra-ventricular dyssynchrony. J Am Coll Cardiol 48 (2006) 1953-1960
36. Ypenburg C., Roes S.D., Bleeker G.B., et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 99 (2007) 657-660